Conjugated Polymer Nanoparticles
Product News Oct 01, 2019
Stream Bio, a company that develops and manufactures a range of bioimaging molecular probes, has announced the release of its Conjugated Polymer Nanoparticles (CPNs™).
Stream Bio’s CPNs have applications in diagnostics and therapeutics, with the potential to be used for imaging tumors and fluorescence-guided surgery. Highly fluorescent, non-toxic nanoparticles could transform the bioimaging market with their unique brightness, stability, magnetic capability and suitability for conjugation with a wide range of molecules.
Currently, CPNs are available in four wavelengths; 475nm, 510nm, 550nm and 680nm. They can also be purchased in a conjugated form, with fluorescent streptavidin covalently attached. This enables them to be used in different protocols for the detection of a variety of proteins, protein motifs, nucleic acids, and other biomolecules.
Initially, a small range of unconjugated CPNs will be available to purchase from Sigma Aldrich, with a wider range of products soon to be included in the listing.